Developmental and therapeutic implications of IL4ra expression for rhabdomyosarcoma-Reference-Cited by-同舟云学术

Developmental and therapeutic implications of IL4ra expression for rhabdomyosarcoma

Published:2024-06-08 Issue:4 Volume:33 Page:229-241
ISSN:0962-8819
Container-title:Transgenic Research
language:en
Short-container-title:Transgenic Res

Author:

Edwards David W.,Kroepfl Gabrielle M.,Jackson Jacob M.,Chen Sonja,Hudson-Price Lisa,Srinivasa Ganapati,Kannan Kavya,Liu Qianqian,Michalek Joel E.,Keller Charles^ORCID

Funder

National Cancer Institute

Team Megan Bugg and Maddie’s Promise Foundation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11248-024-00390-0.pdf

Reference20 articles.

1. Abraham J, Chua YX, Glover JM, Tyner JW, Loriaux MM, Kilcoyne A et al (2012) An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma. Biochem Biophys Res Commun 426(3):363–368. https://doi.org/10.1016/j.bbrc.2012.08.092

2. Abraham J, Nunez-Alvarez Y, Hettmer S, Carrio E, Chen HI, Nishijo K et al (2014) Lineage of origin in rhabdomyosarcoma informs pharmacological response. Genes Dev 28(14):1578–1591. https://doi.org/10.1101/gad.238733.114

3. Bharathy N, Berlow NE, Wang E, Abraham J, Settelmeyer TP, Hooper JE et al (2018) The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma. Sci Signal. https://doi.org/10.1126/scisignal.aau7632

4. Cleary MM, Mansoor A, Settelmeyer T, Ijiri Y, Ladner KJ, Svalina MN et al (2017) NFkappaB signaling in alveolar rhabdomyosarcoma. Dis Model Mech 10(9):1109–1115. https://doi.org/10.1242/dmm.030882

5. Cleary MM, Bharathy N, Abraham J, Kim JA, Rudzinski ER, Michalek JE et al (2021) Interleukin-4 receptor inhibition targeting metastasis independent of macrophages. Mol Cancer Ther 20(5):906–914. https://doi.org/10.1158/1535-7163.MCT-20-0199